source: Pharma Marketing Blog

As reported in FDAnews Drug Daily Bulletin, I recently had a discussion with Fabio Gratton, chief innovation officer of Ignite Health [and member of the ePharma Pioneer Club], who said pharma marketers should find ways to use social media without fear of regulatory hardships. (continued)

Read complete article.
 

Source: ePharma Pioneer Club

Today's guest on the Pharma Marketing Talk streaming audio show was Fabio Gratton, Co-founder, Chief Innovation Officer, Ignite Health, and ePharma Pioneer Club™ member.

We talked about why so few pharmaceutical companies have leveraged the power of social networks to communicate with consumers/patients and how marketers should think differently about the metrics that constitute success. Also, at the end of the show, Fabio had some ideas for how pharmaceutical companies can leverage social networks to improve the health of all US citizens while improving their public image. (continued)

Read Complete Article.

Listen to the podcast.

Source: Medical Marketing & Media

“It reminds me of eight years ago, when the e-channel was becoming more prominent and people were saying ‘We need the brand to have a presence at the brand.com level' and not many companies had the expertise,” says Fabio Gratton, chief innovation officer at Ignite Health. “This is a similar challenge, but much more complex, because the technology is evolving at the speed of light.”  (continued)

Read Complete Article.

Source: Pharma Blogosphere

There are only 3 degrees of separation between me and Kevin Bacon! I know and have hung out with Fabio Gratton, who was Tom Cruise's personal assistant, and Tom Cruise was in the movie A Few Good Men with Kevin Bacon! (continued)

Read Complete Article.

Source: Pharmaceutical Executive

Two weeks ago, Shire received a warning letter for posting a sponsored testimonial on YouTube without including risk information. Shire was very open when I called them up and admitted that the video was posted by accident and immediately removed when it was brought to the company’s attention. (continued)

Read Complete Article.